格隆汇8月22日｜寒武纪(688256.SH)20CM涨停，股价报1243.2元，为A股市场第二高价股，仅次于贵州茅台，且距贵州茅台(1461元)股价仅差218元。寒 武纪年内累涨89%，最新市值升破5200亿元。 股市慢牛来了，你准备好了吗？备好账户跟进牛市，更有五大福利领取>> ...

Group 1 - The core point of the article is that Cambrian has reached a market capitalization of nearly 520 billion yuan, with its stock price hitting 1,243.20 yuan, which is only about 200 yuan less than the stock price of Kweichow Moutai [2]

格隆汇8月22日｜寒武纪-U20CM涨停，股价报1243.2元，为A股市场第二高价股，仅次于贵州茅台，且距贵州茅台(1461元)股价仅差218元。寒武纪年内累 涨89%，最新市值升破5200亿元。 ...

人民财讯8月22日电，寒武纪午后再度拉升，盘中股价突破1200元，现涨超16%，市值超5000亿元。 ...

寒武纪盘中涨超15%，市值突破5000亿，股价逼近1200元，创历史新高。 ...

Group 1 - The EU and the US announced a new trade agreement on August 21, detailing that the US will impose a 15% tariff on most EU goods, including cars, pharmaceuticals, semiconductors, and timber, while exempting certain natural resources, aircraft, and generics [1] - The EU will eliminate tariffs on US industrial products and provide preferential market access for US seafood and agricultural products, with plans to purchase $750 billion of US liquefied natural gas, oil, and nuclear products by 2028, along with $40 billion in US AI chips [1] - The EU is expected to increase its investment in US strategic industries by $600 billion, indicating a significant shift in economic relations [1] Group 2 - EU officials and experts express concerns that the agreement is unfair and will negatively impact the European economy, highlighting an imbalance favoring the US [3][5] - The EU's trade commissioner confirmed that important sectors like wine and spirits were not included in the tariff reduction list, indicating ongoing negotiations to address these key interests [3] - The agreement is viewed as a "loss control document" for the EU, reflecting a deeper dependency on the US and potential friction points that may arise in the future [5]

每经AI快讯，寒武纪涨7.14%，报1112元/股，股价再创新高，总市值突破4647亿元。 （文章来源：每日经济新闻） ...

上证报中国证券网讯 截至8月22日9时37分，寒武纪拉升涨超8%，股价突破1100元关口，总市值近4700亿元。 | <V | 寒武纪-U ① | | | | --- | --- | --- | --- | | | 688256 科创板 融 沪股通 未盈利 ▼ | | | | 1122.49 今开 1075.00 最高 | 1126.00 最低 | | | | 8.35% 86.49 快手 | 0.54% 总手 | 22682 金额 | | | 总值 4696亿 流值 | 4696亿 市盈 330.27 | | | | 分时 王日 | 目K 周Ｋ | | 目K | | 1126.00 | 8.69% | | 卖５ 112 | | | | | 卖4 112 卖3 112 | | | | | 卖2 112 | | | | | 卖1 112 | | 1036.00- | | | 买1 112 | | | | | 买2 112 | | | | | 录3 112 | | | | | 买4 112 | | | | | 112 조 5 | | 946.00 | -8.69% | | 分明 | | 量比 5.944 | | ...

Core Points - The U.S. and EU have reached a significant breakthrough in trade negotiations, agreeing on a framework for a "Reciprocal, Fair, and Balanced Trade Agreement" [1][2] - The framework includes commitments from both sides regarding tariffs, market access, and investment, with the EU agreeing to eliminate tariffs on all U.S. industrial goods [5][6] - The U.S. will maintain a 15% tariff on most goods imported from the EU, with specific conditions for reducing auto tariffs [1][4] Tariff and Market Access - The EU will eliminate tariffs on all U.S. industrial products and provide better market access for various U.S. seafood and agricultural products [5] - The U.S. will apply the most favored nation (MFN) rate or a 15% tariff on goods from the EU, whichever is higher, starting from September 1, 2025, for certain products [5][6] - The U.S. has committed to reducing tariffs on pharmaceuticals, semiconductors, and wood products from the EU, ensuring rates do not exceed 15% [5][6] Procurement and Investment - The EU has committed to purchasing $750 billion worth of U.S. liquefied natural gas (LNG), oil, and nuclear products by 2028 [7] - The EU plans to invest $600 billion in strategic sectors in the U.S. by 2028, enhancing transatlantic economic cooperation [7] - Both parties will work to reduce non-tariff barriers, particularly in the automotive sector, and simplify sanitary certificate requirements for food and agricultural products [7] Environmental and Climate Change - The EU has promised to provide more flexibility in the implementation of the Carbon Border Adjustment Mechanism (CBAM) to support U.S. small and medium-sized enterprises [8] - The EU will ensure that sustainability directives do not impose undue restrictions on transatlantic trade [8]

Core Viewpoint - The stock price of Cambrian Biologics has risen over 4% on August 21, reaching a historical high and a market capitalization of 440 billion CNY [1]. Group 1: Stock Performance - Cambrian Biologics' stock price increased by 7.06% with a trading volume of 6.359 billion CNY [2]. - The stock opened at 1020.00 CNY, with a highest price of 1066.00 CNY and a lowest price of 1005.57 CNY, resulting in a trading amplitude of 5.97% [2]. - The total market value of Cambrian Biologics is reported to be 441.4 billion CNY, with a circulating market value of 441.4 billion CNY [2]. Group 2: Financial Metrics - The earnings per share (EPS) for Cambrian Biologics is 0.31, with an estimated EPS of 3.87 for 2025 [2]. - The total share capital is 418 million shares, with a free float of 203 million shares [2]. - The price-to-earnings ratio (P/E) is reported at 3400, while the price-to-book ratio (P/B) stands at 74.87 [2].